BN104 clinical trials
BN104 is named as an intervention in 2 current clinical trials in our China register. 1 is recruiting patients now. The most common phase is Phase 1/2. The sponsor with the most trials is Institut de Recherches Internationales Servier (I.R.I.S.) (1). The most-studied condition is ALL, Adult.
How BN104 works
All drug targets →- Acute lymphoblastic leukemiaPhase 1/2
- Acute myeloid leukemiaPhase 1/2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL6068545, CC BY-SA 3.0. The Guide to Pharmacology has no record of this medicine, so its targets rest on ChEMBL alone. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for BN104
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of BN104
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
NCT07101497 · ClinicalTrials.gov ↗ · Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy
|
Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | China |
|
A Study of BN104 in the Treatment of Acute Leukemia
NCT06052813 · ClinicalTrials.gov ↗ · ALL, Adult, AML, Adult, Acute Leukaemia
|
Phase 1/2 | Active, closed | Institut de Recherches Internationales Servier (I.R.I.S.) | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with BN104
8 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Institut de Recherches Internationales Servier (I.R.I.S.) | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about BN104 trials
How many clinical trials are testing BN104?
2 current trials in our China register name BN104 as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are BN104 trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors BN104 clinical trials?
Institut de Recherches Internationales Servier (I.R.I.S.) (1) and The First Affiliated Hospital of Soochow University (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how BN104 works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how BN104 works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists BN104 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.